Prekshi Garg
Prekshi Garg has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Prachi Srivastava
Amity University Uttar Pradesh, Lucknow Campus
5 shared publications - Neha Srivastava
Amity Institute of Biotechnology, Amity University, Uttar Pradesh, Lucknow Campus, Lucknow 226010, India
2 shared publications - Ananya Singh
Amity Institute of Biotechnology, Amity University, Uttar Pradesh, Lucknow, Campus, 226028, India
1 shared publication - Farrukh Jamal
Department of Biochemistry Dr. Ram Manohar Lohia Avadh University Faizabad Uttar Pradesh India
1 shared publication - Neha Srivastava
Pharma Analytics Department, Excelra knowledge Solution Pvt Ltd, Hyderabad, Telegana, India
1 shared publication Prachi Srivastava
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, 226028, India
1 shared publication
Latest Publications
- 10 January 2026
- Published by Elsevier in Gene Expression Patterns
- Vol. 57, 119406
Exploring NPM1P51 as a key biomarker for glaucoma by integrating differential gene expression analysis and artificial neural network models
- 10 January 2026
- Published by Elsevier in Gene Expression Patterns
- Vol. 57, 119406
Exploring NPM1P51 as a key biomarker for glaucoma by integrating differential gene expression analysis and artificial neural network models
- Open Access
- 16 June 2023
- Published by Elsevier in Informatics in Medicine Unlocked
- Vol. 40, 101282
Identification of priority genes involved in ADHD using multiple system biology approach and establishment of Asiatic acid as a natural inhibitor against GRIN2B receptor
- 16 June 2023
- Published by Elsevier in Informatics in Medicine Unlocked
- Vol. 40, 101282
Open AccessIdentification of priority genes involved in ADHD using multiple system biology approach and establishment of Asiatic acid as a natural inhibitor against GRIN2B receptor
- 1 November 2022
- Published by Springer Nature in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
- Vol. 93 (2) , 325-335
In Silico Study of ULK1 Gene as a Susceptible Biomarker for Neurodegeneration
- 1 November 2022
- Published by Springer Nature in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
- Vol. 93 (2) , 325-335
In Silico Study of ULK1 Gene as a Susceptible Biomarker for Neurodegeneration
- Open Access
- 30 September 2022
- Published by MDPI AG in Biology and Life Sciences Forum
- Vol. 19 (1) , 20
Meta-Analysis of RNA-Seq Data Identifies Potent Biomarkers for Intellectual Disability Disorder (IDD)
The identification of genes that are expressed differentially in the diseased versus healthy individual give relevant information regarding the pathology of the disease. The identification of DEGs can be a significant step in the field of clinical and pharmaceutical research. They can act as a potent biomarker, therapeutic target, or gene signature for the early diagnosis of the disease. Intellectual disability is a neurodevelopmental disorder that affects those at the fetal stage. Timely diagnosis of the disease can help in preventing severe neurodevelopmental delay in the child. In the current study, a meta-analysis approach was applied for the identification of the DEGs in patients of intellectual disability disorder. Six intellectual disability datasets were retrieved from the GEO database of NCBI and were subjected to quality check, trimming, and alignment. Post-alignment, FeatureCounts was used to form a raw gene count file for differential analysis. The differentially expressed genes were analyzed using the EdgeR statistical package of R Studio. The genes which had an FDR p-value less than 0.05 and log2foldchange greater than 0 were considered upregulated and significantly expressed genes. The study found MTRNR2L1, PAPSS2, L1CAM, IGLV1-47, IGLV3-19, and IGKV1-16 genes to be upregulated in the patient sample. These genes can thus play an important role in the progression of intellectual disability disorder that facilitates early diagnosis of the disease.
- 30 September 2022
- Published by MDPI AG in Biology and Life Sciences Forum
- Vol. 19 (1) , 20
Open AccessMeta-Analysis of RNA-Seq Data Identifies Potent Biomarkers for Intellectual Disability Disorder (IDD)
The identification of genes that are expressed differentially in the diseased versus healthy individual give relevant information regarding the pathology of the disease. The identification of DEGs can be a significant step in the field of clinical and pharmaceutical research. They can act as a potent biomarker, therapeutic target, or gene signature for the early diagnosis of the disease. Intellectual disability is a neurodevelopmental disorder that affects those at the fetal stage. Timely diagnosis of the disease can help in preventing severe neurodevelopmental delay in the child. In the current study, a meta-analysis approach was applied for the identification of the DEGs in patients of intellectual disability disorder. Six intellectual disability datasets were retrieved from the GEO database of NCBI and were subjected to quality check, trimming, and alignment. Post-alignment, FeatureCounts was used to form a raw gene count file for differential analysis. The differentially expressed genes were analyzed using the EdgeR statistical package of R Studio. The genes which had an FDR p-value less than 0.05 and log2foldchange greater than 0 were considered upregulated and significantly expressed genes. The study found MTRNR2L1, PAPSS2, L1CAM, IGLV1-47, IGLV3-19, and IGKV1-16 genes to be upregulated in the patient sample. These genes can thus play an important role in the progression of intellectual disability disorder that facilitates early diagnosis of the disease.
- Open Access
- 10 January 2022
- Published by Maad Rayan Publishing Company in Environmental Health Engineering and Management
- Vol. 9 (1) , 33-40
Comparative investigation to analyse the critical role of NFE2L2 gene in heavy metal induced toxicity through in silico approaches
Background: Accumulation of heavy metals like copper, nickel, arsenic, cobalt, and cadmium are increasing day by day. Accumulation of these heavy metals poses serious threats to human health. Elemental toxicity percentage has been found to be increased day-by-day and creating different minor to major problems from tissue to the gene level. Different important gene expressions are altered due to the contamination of such heavy metals. The present study aimed to identify a common target gene that is involved in the toxicity of major heavy metals and to study the major impact of the gene on the concerned biological system. Methods: In the progression of the work, major genes involved in copper, nickel, arsenic, cobalt, and cadmium toxicity were listed through intense data curation, and a pathway showing the correlation and physical interaction of all the genes that were constructed using in-silico tools STRING and Gene Mania database. Further, functional and expression analysis of the discovered gene was done using in-silico tools like genome-wide association study (GWAS), genotype-tissue expression (GTEx), and RegulomeDB. Results: According to the network analysis, NFE2L2 was recognized as a common target involved in the above-mentioned heavy metals toxicity. Expression analysis revealed that the highest expression of NFE2L2 was observed in tissues of oesophagus, ovary, bladder, vagina, thyroid, and skin. Detailed investigation at the pathway level revealed that the involvement was importantly observed in immunodeficiency and developmental delay. Conclusion: The study opened a wide vision that the major target of such toxicants is various pathways of neurobiological distress and biological processes, and hence, it can be considered as a susceptible target for heavy metals-induced toxicity.
- 10 January 2022
- Published by Maad Rayan Publishing Company in Environmental Health Engineering and Management
- Vol. 9 (1) , 33-40
Open AccessComparative investigation to analyse the critical role of NFE2L2 gene in heavy metal induced toxicity through in silico approaches
Background: Accumulation of heavy metals like copper, nickel, arsenic, cobalt, and cadmium are increasing day by day. Accumulation of these heavy metals poses serious threats to human health. Elemental toxicity percentage has been found to be increased day-by-day and creating different minor to major problems from tissue to the gene level. Different important gene expressions are altered due to the contamination of such heavy metals. The present study aimed to identify a common target gene that is involved in the toxicity of major heavy metals and to study the major impact of the gene on the concerned biological system. Methods: In the progression of the work, major genes involved in copper, nickel, arsenic, cobalt, and cadmium toxicity were listed through intense data curation, and a pathway showing the correlation and physical interaction of all the genes that were constructed using in-silico tools STRING and Gene Mania database. Further, functional and expression analysis of the discovered gene was done using in-silico tools like genome-wide association study (GWAS), genotype-tissue expression (GTEx), and RegulomeDB. Results: According to the network analysis, NFE2L2 was recognized as a common target involved in the above-mentioned heavy metals toxicity. Expression analysis revealed that the highest expression of NFE2L2 was observed in tissues of oesophagus, ovary, bladder, vagina, thyroid, and skin. Detailed investigation at the pathway level revealed that the involvement was importantly observed in immunodeficiency and developmental delay. Conclusion: The study opened a wide vision that the major target of such toxicants is various pathways of neurobiological distress and biological processes, and hence, it can be considered as a susceptible target for heavy metals-induced toxicity.
- Open Access
- 24 May 2020
- Published by MDPI AG in Preprints.org
An Integrated In-Silico Approach to Develop Epitope-Based Peptide Vaccine against SARS-CoV-2
SARS-CoV-2 has been the talk of the town ever since the beginning of 2020. The pandemic has brought the complete world on a halt. Every country is trying all possible steps to combat the disease ranging from shutting the complete economy of the country to repurposing of drugs and vaccine development. The rapid data analysis and widespread tools, software and databases have made bioinformatics capable of giving new insights to the researchers to deal with the current scenario more efficiently. Vaccinomics, the new emerging field of bioinformatics uses concepts of immunogenetics and immunogenomics with in silico tools to give promising results for wet lab experiments. This approach is highly validated for the designing and development of potent vaccines. The present in-silico study was attempted to identify peptide fragments from spike surface glycoprotein that can be efficiently used for the designing and development of epitope-based vaccine designing approach. Both B-cell and T-cell epitopes are predicted using integrated computational tools. VaxiJen server was used for prediction of protective antigenicity of the protein. NetCTL was studied for analyzing most potent T cell epitopes and its subsequent MHC-I interaction through tools provided by IEDB. 3D structure prediction of peptides and MHC-I alleles (HLA-C*03:03) was further done to carry out docking studies using AutoDock4.0. Various tools from IEDB were used to predict B-cell epitopes on the basis of different essential parameters like surface accessibility, beta turns and many more. Based on results interpretation, the peptide sequence from 1138-1145 amino acid and sequence WTAGAAAYY and YDPLQPEL were obtained as a potential B-cell epitope and T-cell epitope respectively. This in-silico study will help us to identify novel epitope-based peptide vaccine target in spike protein of SARS-CoV-2. Further, in-vitro and in-vivo study needed to validate the findings.
- 24 May 2020
- Published by MDPI AG in Preprints.org
Open AccessAn Integrated In-Silico Approach to Develop Epitope-Based Peptide Vaccine against SARS-CoV-2
SARS-CoV-2 has been the talk of the town ever since the beginning of 2020. The pandemic has brought the complete world on a halt. Every country is trying all possible steps to combat the disease ranging from shutting the complete economy of the country to repurposing of drugs and vaccine development. The rapid data analysis and widespread tools, software and databases have made bioinformatics capable of giving new insights to the researchers to deal with the current scenario more efficiently. Vaccinomics, the new emerging field of bioinformatics uses concepts of immunogenetics and immunogenomics with in silico tools to give promising results for wet lab experiments. This approach is highly validated for the designing and development of potent vaccines. The present in-silico study was attempted to identify peptide fragments from spike surface glycoprotein that can be efficiently used for the designing and development of epitope-based vaccine designing approach. Both B-cell and T-cell epitopes are predicted using integrated computational tools. VaxiJen server was used for prediction of protective antigenicity of the protein. NetCTL was studied for analyzing most potent T cell epitopes and its subsequent MHC-I interaction through tools provided by IEDB. 3D structure prediction of peptides and MHC-I alleles (HLA-C*03:03) was further done to carry out docking studies using AutoDock4.0. Various tools from IEDB were used to predict B-cell epitopes on the basis of different essential parameters like surface accessibility, beta turns and many more. Based on results interpretation, the peptide sequence from 1138-1145 amino acid and sequence WTAGAAAYY and YDPLQPEL were obtained as a potential B-cell epitope and T-cell epitope respectively. This in-silico study will help us to identify novel epitope-based peptide vaccine target in spike protein of SARS-CoV-2. Further, in-vitro and in-vivo study needed to validate the findings.